Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide as Treatment for Fibromyalgia
NCT05357066Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Nov 2021
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitrous oxide in fibromyalgia (FM), sponsored by University of Chicago. Planned start Nov 2021; status: withdrawn.
02
Drugs
nitrous oxide
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05357066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357066.